MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 105 filers reported holding MEI PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $84,000 | -3.4% | 31,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $87,000 | +31.8% | 31,500 | +37.0% | 0.00% | 0.0% |
| Q2 2021 | $66,000 | -16.5% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $79,000 | +29.5% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $61,000 | -62.3% | 23,000 | -55.7% | 0.00% | -75.0% |
| Q3 2020 | $162,000 | +44.6% | 51,959 | +91.8% | 0.01% | +33.3% |
| Q2 2020 | $112,000 | +173.2% | 27,095 | +78.3% | 0.01% | +50.0% |
| Q3 2017 | $41,000 | -34.9% | 15,200 | -42.6% | 0.00% | -33.3% |
| Q2 2017 | $63,000 | +40.0% | 26,500 | -4.0% | 0.01% | +50.0% |
| Q1 2017 | $45,000 | +1400.0% | 27,600 | +1433.3% | 0.00% | – |
| Q3 2016 | $3,000 | – | 1,800 | +800.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 200 | -90.0% | 0.00% | -100.0% |
| Q1 2013 | $17,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 4,610,423 | $1,782,000 | 0.21% |
| DAFNA Capital Management LLC | 1,767,146 | $683,000 | 0.18% |
| NEA Management Company, LLC | 8,533,072 | $3,299,000 | 0.16% |
| Boxer Capital, LLC | 2,913,091 | $1,126,000 | 0.06% |
| BVF INC/IL | 3,532,057 | $1,365,000 | 0.06% |
| Investmark Advisory Group LLC | 136,000 | $52,000 | 0.05% |
| CARLSON CAPITAL L P | 1,150,000 | $445,000 | 0.03% |
| Artal Group S.A. | 1,000,000 | $387,000 | 0.02% |
| Annandale Capital, LLC | 100,000 | $39,000 | 0.01% |
| Sigma Planning Corp | 641,050 | $248,000 | 0.01% |